Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company […]
Vital Connect
Study: Wearable AI-powered biosensors show promise for HF detection
Wearable biosenors with artificial intelligence-based analytics can provide accurate early detection of impending rehospitalization similar to implanted devices, according to data from a new study backed by the US Dept. of Veterans Affairs. The trial explored the ability of wearable sensors, developed by VitalConnect, supported by AI-driven analytics, developed by PhysIQ, to effectively predict heart […]
VitalConnect wins FDA 510(k) extension for VitalPatch
Wearable biometric diagnostic patch company VitalConnect said it won an extended FDA 510(k) from the FDA for its VitalPatch wearable biosensor, extending the wear duration from four days to five days. VitalConnect touts the VitalPatch as the smallest and lightest biosensor designed to measure a combination of single-lead ECG, heart rate, heart rate variability, respiratory rate, skin […]
VitalConnect closes $20m term loan
Wearable biometric diagnostic patch company VitalConnect has closed a $20 million senior secured term loan with Oxford Finance, according to a press release from the finance firm. VitalConnect produces the VitalPatch wearable biosensor, as well as its VitalConnect Platform to enable monitoring of the patch’s sensor data. The company’s devices can return multiple measurements in a single […]
VitalConnect closes $38m Series C
Wearable biometric diagnostic patch company VitalConnect said yesterday it raised $38 million in its fourth and final Series C closing, with funds slated to support the launch of its VitalConnect platform and VitalPatch wearable. The round was led by MVM and joined by Baxter‘s (NYSE:BAX) venture arm, Baxter Ventures, the San Jose, Calif.-based company said. VitalConnect produces the […]
VitalConnect closes $33m Series C round
Wearable biometric diagnostic patch company VitalConnect said today it closed a $33 million Series C preferred stock financing round. The funding round was led by newly invested MVM Life Science Partners and Baxter Ventures, the San Jose, Calif.-based company said. As part of the round, MVM founder Dr. Stephen Reeders will join the company’s board of directors. “MVM […]
VitalConnect brings in $25m
Wearable biometric diagnostic patch company VitalConnect said yesterday it raised a total of $25 million through the closure of a loan facility and an extended Series B financing round to support the commercialization of its HealthPatch MD and VitalPatch biosensors. The company said it closed a term loan facility for $17.5 with Perceptive Advisors, with […]
Vital Connect raises $18m for wearable biosensors
Wearable biometric diagnostic patch company Vital Connect raised $18 million in a new round of equity financing, according to a new SEC filing. The company is developing the Vital Connect platform designed to work with its HealthPatch MD and VitalPatch biosensors. Vital Connect’s devices can return multiple measurements in a single biosensor patch, including single-lead […]
